These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 3451374)

  • 21. The effect of oxyphenonium bromide and oxybutynin hydrochloride on detrusor contractility and reflux in children with vesicoureteral reflux and detrusor instability.
    Scholtmeijer RJ; van Mastrigt R
    J Urol; 1991 Aug; 146(2 ( Pt 2)):660-2. PubMed ID: 1907331
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Value of intravesically instilled oxybutynin in refractory bladder hyperactivity. Study of 15 cases].
    Amarenco G; Adba MA; Kerdraon J
    Prog Urol; 1992; 2(4):660-3. PubMed ID: 1302108
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Trospium chloride and oxybutynin hydrochloride in a german study of adults with urinary urge incontinence: results of a 12-week, multicenter, randomized, double-blind, parallel-group, flexible-dose noninferiority trial.
    Zellner M; Madersbacher H; Palmtag H; Stöhrer M; Bödeker RH;
    Clin Ther; 2009 Nov; 31(11):2519-39. PubMed ID: 20109997
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transdermal oxybutynin. A viewpoint by Adrian Wagg.
    Wagg A
    Drugs Aging; 2003; 20(11):865-6. PubMed ID: 12964894
    [No Abstract]   [Full Text] [Related]  

  • 25. Comparison of the efficacy, safety, and tolerability of propiverine and oxybutynin for the treatment of overactive bladder syndrome.
    Schaefer W
    Int J Urol; 2007 Jul; 14(7):670; author reply 670-1. PubMed ID: 17645621
    [No Abstract]   [Full Text] [Related]  

  • 26. Idiopathic bladder hyperactivity treated with Ditropan (oxybutynin chloride).
    Nagy F; Hamvas A; Frang D
    Int Urol Nephrol; 1990; 22(6):519-24. PubMed ID: 2093692
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Is extended-release oxybutynin (Ditropan XL) or tolterodine (Detrol) more effective in the treatment of an overactive bladder?
    Hartnett NM; Saver BG
    J Fam Pract; 2001 Jul; 50(7):571. PubMed ID: 11485700
    [No Abstract]   [Full Text] [Related]  

  • 28. An extended-release formulation of oxybutynin chloride for the treatment of overactive urinary bladder.
    Goldenberg MM
    Clin Ther; 1999 Apr; 21(4):634-42. PubMed ID: 10363730
    [TBL] [Abstract][Full Text] [Related]  

  • 29. This month in investigative urology: new insights into the clinical value of oxybutynin.
    Chai TC
    J Urol; 1998 Sep; 160(3 Pt 1):644. PubMed ID: 9720514
    [No Abstract]   [Full Text] [Related]  

  • 30. Oxybutinin versus propantheline in the management of detrusor instability. A patient-regulated variable dose trial.
    Holmes DM; Montz FJ; Stanton SL
    Br J Obstet Gynaecol; 1989 May; 96(5):607-12. PubMed ID: 2667633
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transdermal oxybutynin. A viewpoint by Michael Chancellor.
    Chancellor M
    Drugs Aging; 2003; 20(11):865-6. PubMed ID: 12964893
    [No Abstract]   [Full Text] [Related]  

  • 32. Oxybutynin for diabetic complications.
    Chideckel EW
    JAMA; 1990 Dec; 264(23):2994. PubMed ID: 2243424
    [No Abstract]   [Full Text] [Related]  

  • 33. Oxybutynin: a new drug with analgesic and anticholinergic properties.
    Diokno AC; Lapides J
    J Urol; 1972 Aug; 108(2):307-9. PubMed ID: 5047425
    [No Abstract]   [Full Text] [Related]  

  • 34. Oxybutynin administration diminishes the high gastric muscular tone associated with bladder reconstruction.
    Sheldon CA; Reeves D; Lewis AG
    J Urol; 1995 Feb; 153(2):461-2. PubMed ID: 7815620
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Assessment of the use of oxybutynin hydrochloride (Pollakisu tablets) in the elderly].
    Uchibayashi T; Nakajima K; Nihino A; Hisazumi H
    Hinyokika Kiyo; 1991 Sep; 37(9):1077-85. PubMed ID: 1785418
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Oxybutynin chloride in pediatrics: extenuating circumstances].
    Aubert D
    Arch Fr Pediatr; 1988 May; 45(5):375-6. PubMed ID: 3415420
    [No Abstract]   [Full Text] [Related]  

  • 37. Terodiline and oxybutynin in detrusor instability.
    Drug Ther Bull; 1988 May; 26(10):37-8. PubMed ID: 3383752
    [No Abstract]   [Full Text] [Related]  

  • 38. The unstable bladder.
    Mundy AR
    Urol Clin North Am; 1985 May; 12(2):317-28. PubMed ID: 3992747
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tethered cord syndrome in an adult. Pharmacological treatment of the urological symptomatology by oxybutynin.
    De Angelis M; Martina G; Caverni L; Coglitore A; Libanori GP; Giannotti P
    Acta Urol Belg; 1986; 54(1):99-105. PubMed ID: 3962800
    [No Abstract]   [Full Text] [Related]  

  • 40. The treatment of detrusor instability in postmenopausal women with oxybutynin chloride: a double blind placebo controlled study.
    Moore KH; Goldstein M; Hay D
    Br J Obstet Gynaecol; 1990 Nov; 97(11):1063-4. PubMed ID: 2082973
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.